220 related articles for article (PubMed ID: 10818025)
1. Meta-analysis of increased dose of inhaled steroid or addition of salmeterol in symptomatic asthma (MIASMA).
Shrewsbury S; Pyke S; Britton M
BMJ; 2000 May; 320(7246):1368-73. PubMed ID: 10818025
[TBL] [Abstract][Full Text] [Related]
2. Salmeterol xinafoate as maintenance therapy compared with albuterol in patients with asthma.
D'Alonzo GE; Nathan RA; Henochowicz S; Morris RJ; Ratner P; Rennard SI
JAMA; 1994 May; 271(18):1412-6. PubMed ID: 7909853
[TBL] [Abstract][Full Text] [Related]
3. Effect of beta2-adrenergic receptor polymorphism on response to longacting beta2 agonist in asthma (LARGE trial): a genotype-stratified, randomised, placebo-controlled, crossover trial.
Wechsler ME; Kunselman SJ; Chinchilli VM; Bleecker E; Boushey HA; Calhoun WJ; Ameredes BT; Castro M; Craig TJ; Denlinger L; Fahy JV; Jarjour N; Kazani S; Kim S; Kraft M; Lazarus SC; Lemanske RF; Markezich A; Martin RJ; Permaul P; Peters SP; Ramsdell J; Sorkness CA; Sutherland ER; Szefler SJ; Walter MJ; Wasserman SI; Israel E;
Lancet; 2009 Nov; 374(9703):1754-64. PubMed ID: 19932356
[TBL] [Abstract][Full Text] [Related]
4. Concurrent use of salmeterol with inhaled corticosteroids is more effective than inhaled corticosteroid dose increases.
Murray JJ; Church NL; Anderson WH; Bernstein DI; Wenzel SE; Emmett A; Rickard KA
Allergy Asthma Proc; 1999; 20(3):173-80. PubMed ID: 10389550
[TBL] [Abstract][Full Text] [Related]
5. Effect of long-term treatment with salmeterol on asthma control: a double blind, randomised crossover study.
Wilding P; Clark M; Thompson Coon J; Lewis S; Rushton L; Bennett J; Oborne J; Cooper S; Tattersfield AE
BMJ; 1997 May; 314(7092):1441-6. PubMed ID: 9167559
[TBL] [Abstract][Full Text] [Related]
6. Addition of long-acting beta2-agonists to inhaled corticosteroids for chronic asthma in children.
Chauhan BF; Chartrand C; Ni Chroinin M; Milan SJ; Ducharme FM
Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD007949. PubMed ID: 26594816
[TBL] [Abstract][Full Text] [Related]
7. Salmeterol reduces the need for inhaled corticosteroid in steroid-dependent asthmatics.
Nielsen LP; Pedersen B; Faurschou P; Madsen F; Wilcke JT; Dahl R
Respir Med; 1999 Dec; 93(12):863-8. PubMed ID: 10653047
[TBL] [Abstract][Full Text] [Related]
8. Effect of addition of inhaled salmeterol to the treatment of moderate-to-severe asthmatics uncontrolled on high-dose inhaled steroids. European Respiratory Study Group.
Faurschou P; Steffensen I; Jacques L
Eur Respir J; 1996 Sep; 9(9):1885-90. PubMed ID: 8880107
[TBL] [Abstract][Full Text] [Related]
9. Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids.
Woolcock A; Lundback B; Ringdal N; Jacques LA
Am J Respir Crit Care Med; 1996 May; 153(5):1481-8. PubMed ID: 8630590
[TBL] [Abstract][Full Text] [Related]
10. Addition of salmeterol to fluticasone propionate treatment in moderate-to-severe asthma.
Ind PW; Dal Negro R; Colman NC; Fletcher CP; Browning D; James MH
Respir Med; 2003 May; 97(5):555-62. PubMed ID: 12735675
[TBL] [Abstract][Full Text] [Related]
11. Combined salmeterol/fluticasone propionate versus fluticasone propionate alone in mild asthma : a placebo-controlled comparison.
Boonsawat W; Goryachkina L; Jacques L; Frith L
Clin Drug Investig; 2008; 28(2):101-11. PubMed ID: 18211118
[TBL] [Abstract][Full Text] [Related]
12. Salmeterol/fluticasone propionate (50/500 microg) in combination in a Diskus inhaler (Seretide) is effective and safe in the treatment of steroid-dependent asthma.
Aubier M; Pieters WR; Schlösser NJ; Steinmetz KO
Respir Med; 1999 Dec; 93(12):876-84. PubMed ID: 10653049
[TBL] [Abstract][Full Text] [Related]
13. Salmeterol improves quality of life in patients with asthma requiring inhaled corticosteroids. Salmeterol Quality of Life Study Group.
Kemp JP; Cook DA; Incaudo GA; Corren J; Kalberg C; Emmett A; Cox FM; Rickard K
J Allergy Clin Immunol; 1998 Feb; 101(2 Pt 1):188-95. PubMed ID: 9500751
[TBL] [Abstract][Full Text] [Related]
14. Regular treatment with formoterol and an inhaled corticosteroid versus regular treatment with salmeterol and an inhaled corticosteroid for chronic asthma: serious adverse events.
O'Shea O; Stovold E; Cates CJ
Cochrane Database Syst Rev; 2021 Apr; 4(4):CD007694. PubMed ID: 33852162
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of salmeterol in childhood asthma.
Lenney W; Pedersen S; Boner AL; Ebbutt A; Jenkins MM
Eur J Pediatr; 1995 Dec; 154(12):983-90. PubMed ID: 8801107
[TBL] [Abstract][Full Text] [Related]
16. Comparison of oral bambuterol and inhaled salmeterol in patients with symptomatic asthma and using inhaled corticosteroids.
Crompton GK; Ayres JG; Basran G; Schiraldi G; Brusasco V; Eivindson A; Jamieson AH; Olsson H
Am J Respir Crit Care Med; 1999 Mar; 159(3):824-8. PubMed ID: 10051257
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
Nathan RA; Rooklin A; Schoaf L; Scott C; Ellsworth A; House K; Dorinsky P
Clin Ther; 2006 Jan; 28(1):73-85. PubMed ID: 16490581
[TBL] [Abstract][Full Text] [Related]
18. A comparison of beclomethasone, salmeterol, and placebo in children with asthma. Canadian Beclomethasone Dipropionate-Salmeterol Xinafoate Study Group.
Simons FE
N Engl J Med; 1997 Dec; 337(23):1659-65. PubMed ID: 9385125
[TBL] [Abstract][Full Text] [Related]
19. Comparison of salmeterol with beclomethasone in adult patients with mild persistent asthma who are already on low-dose inhaled steroids.
Vermetten FA; Boermans AJ; Luiten WD; Mulder PG; Vermue NA
J Asthma; 1999; 36(1):97-106. PubMed ID: 10077139
[TBL] [Abstract][Full Text] [Related]
20. Effects on resource utilization of adding salmeterol in combination or separately to inhaled corticosteroids.
Chan J; Hui RL; Spence MM
J Manag Care Pharm; 2007; 13(1):21-7. PubMed ID: 17269833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
